Biotec
InactiveInactive since 04-09-2026; last annual accounts for fiscal year 2024. Dissolved without liquidation; books and records kept by BELGOCODEX in Lasne.
Signals
This company filed its last 6 accounts on average 20 days after the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, full schema
Click a name to add, emphasise or remove a line.
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €45,384 | €49,519 | €58,037 | €59,032 | ▲ 1.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | - | - | €327 | - |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | -€51,278 | - | -€90,220 | -€41,478 | ▲ 54.0% |
| Other operating charges640/8 | - | €318 | €3,137 | €2,650 | €66,219 | ▲ 2,399% |
| Non-recurring operating charges66A | - | - | - | - | €22,255 | - |
| Gross operating margin9900 | -€54,566 | -€12,030 | -€40,996 | -€8,275 | €543 | ▲ 107% |
| Operating profit (loss)9901 | -€128,391 | -€6,453 | -€93,652 | €21,259 | -€105,811 | ▼ 598% |
| Financial income75/76B | - | €404,150 | €340,999 | €131,457 | €1.6m | ▲ 1,140% |
| Recurring financial income75 | €62,552 | €404,150 | €340,999 | €131,457 | €356,220 | ▲ 171% |
| Non-recurring financial income76B | - | - | - | - | €1.3m | - |
| Financial charges65/66B | - | €299,477 | €524,225 | €140,506 | €69,600 | ▼ 50.5% |
| Recurring financial charges65 | €79,173 | €158,418 | €476,537 | €100,286 | -€10,530 | ▼ 111% |
| Non-recurring financial charges66B | - | €141,059 | €47,688 | €40,220 | €80,130 | ▲ 99.2% |
| Profit (loss) for the period before taxes9903 | -€145,012 | €98,219 | -€276,877 | €12,210 | €1.5m | ▲ 11,818% |
| Income taxes67/77 | -€165 | €30,295 | €4,921 | - | €2,638 | - |
| Profit (loss) for the period9904 | -€144,846 | €67,925 | -€281,799 | €12,210 | €1.5m | ▲ 11,796% |
| Profit (loss) for the period to be appropriated9905 | -€144,846 | €67,925 | -€281,799 | €12,210 | €1.5m | ▲ 11,796% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €7.4m | €7.5m | €5.4m | €6.1m | €5.6m | ▼ 8.6% |
| Fixed assets21/28 | €5.9m | €4.4m | €4.5m | €4.5m | €4.4m | ▼ 1.8% |
| Tangible fixed assets22/27 | €204,154 | €204,154 | €352,511 | €352,511 | €317,429 | ▼ 10.0% |
| Land and buildings22 | - | - | €148,357 | €148,357 | €148,357 | = |
| Furniture and vehicles24 | - | - | - | - | €2,103 | - |
| Other tangible fixed assets26 | - | €204,154 | €204,154 | €204,154 | €166,970 | ▼ 18.2% |
| Financial fixed assets28 | €5.7m | €4.2m | €4.2m | €4.2m | €4.1m | ▼ 1.2% |
| Current assets29/58 | €1.5m | €3.0m | €935,527 | €1.6m | €1.2m | ▼ 27.9% |
| Amounts receivable within one year40/41 | €213,148 | €183,710 | €125,780 | €232,747 | €255,047 | ▲ 9.6% |
| Trade receivables40 | - | €115,500 | €24,200 | €54,450 | €50,347 | ▼ 7.5% |
| Other amounts receivable41 | - | €68,210 | €101,580 | €178,297 | €204,701 | ▲ 14.8% |
| Current investments50/53 | €347,339 | €2.8m | €415,153 | €1.2m | €734,890 | ▼ 40.6% |
| Cash at bank and in hand54/58 | €932,581 | €53,644 | €392,360 | €135,107 | €152,908 | ▲ 13.2% |
| Deferred charges and accrued income490/1 | - | €1,646 | €2,235 | €1,522 | €15,450 | ▲ 915% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €7.4m | €7.5m | €5.4m | €6.1m | €5.6m | ▼ 8.6% |
| Equity10/15 | €4.7m | €2.9m | €2.7m | €2.7m | €4.1m | ▲ 54.5% |
| Contributions10/11 | €11.4m | €9.5m | €9.5m | €9.5m | €9.5m | = |
| Capital10 | - | €9.5m | €9.5m | €9.5m | €9.5m | = |
| Issued capital100 | - | €9.5m | €9.5m | €9.5m | €9.5m | = |
| Reserves13 | €190,413 | €190,413 | €190,413 | €190,413 | €190,413 | = |
| Non-distributable reserves130/1 | - | €190,413 | €190,413 | €190,413 | €190,413 | = |
| Legal reserve130 | - | €190,413 | €190,413 | €190,413 | €190,413 | = |
| Profit (loss) carried forward14 | -€6.9m | -€6.8m | -€7.1m | -€7.1m | -€5.6m | ▲ 20.6% |
| Amounts payable17/49 | €2.7m | €4.5m | €2.8m | €3.5m | €1.5m | ▼ 57.1% |
| Amounts payable after more than one year17 | €1.3m | €1.3m | €1.3m | €1.2m | - | - |
| Other amounts payable178/9 | - | €1.3m | €1.3m | €1.2m | - | - |
| Amounts payable within one year42/48 | €1.4m | €3.3m | €1.5m | €2.3m | €1.5m | ▼ 34.6% |
| Financial debts43 | - | €2.1m | €475,956 | €1.2m | €624,363 | ▼ 48.5% |
| Credit institutions430/8 | - | €2.1m | €475,956 | €1.2m | €624,363 | ▼ 48.5% |
| Trade debts44 | €184,637 | €51,323 | €2,227 | €1,400 | €1,551 | ▲ 10.8% |
| Suppliers440/4 | - | €51,323 | €2,227 | €1,400 | €1,551 | ▲ 10.8% |
| Taxes, remuneration and social security45 | - | €31,948 | €32,397 | €13,606 | €15,925 | ▲ 17.0% |
| Taxes450/3 | - | €23,159 | €24,918 | €4,793 | €4,395 | ▼ 8.3% |
| Remuneration and social security454/9 | - | €8,788 | €7,479 | €8,813 | €11,530 | ▲ 30.8% |
| Other amounts payable47/48 | - | €1.1m | €1.0m | €1.0m | €833,225 | ▼ 19.0% |
| Accrued charges and deferred income492/3 | - | - | €3,135 | €14,853 | €12,431 | ▼ 16.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€144,846 | €67,925 | -€281,799 | €12,210 | €1.5m | ▲ 11,796% |
| + Depreciation and write-downs630 | - | - | - | - | €327 | - |
| Operating cash flow (approximation) | -€144,846 | €67,925 | -€281,799 | €12,210 | €1.5m | ▲ 11,799% |
| Investment in fixed assets (approximation) | - | €1.5m | -€65,750 | -€18,457 | €82,946 | ▲ 549% |
| Change in cash | - | -€878,937 | €338,715 | -€257,253 | €17,801 | ▲ 107% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
15-09
State Gazette act
Merger · General meetingDissolution · Custody of records · Power of attorney6 facts ▸
- Merger, fusion par absorption, unanimité des voix
- General meeting, 28-07-2026
- Dissolution, dissolution sans liquidation, acceptation de la fusion par l'assemblée générale des actionnaires de la société anonyme BELGOCODEX
- Custody of records, 1380 Lasne, Chaussée de Louvain 656, délais prévus par la loi
- Power of attorney, DURAKU Vanessa
- Other statement, declaration pro fisco, articles 117 § 1 et 120 du code des droits d'enregistrement, 211, paragraphe un et suivants du code des impôts sur les revenus 1992 et de…
19-06
State Gazette act
RestructuringMerger · Accounting effect · Shareholding4 facts ▸
- Board meeting, 05-06-2026
- Merger, Operation assimilée (dissolution sans liquidation), absorption
- Accounting effect, 01-01-2026
- Shareholding, 61813
27-03
State Gazette act
Resignations: Servim sa (director) and Bernard Delwart (permanent representative)Registered-office move5 facts ▸
- General meeting, 09/12/2025
- Registered-office move, chaussée de Louvain, 656 à 1380 Ohain
- General meeting, 12/01/2026
- Director resignation, Servim sa (director)
- Director resignation, Bernard Delwart (permanent representative)
Show earlier events
About the unread acts
Of the 15 Belgian State Gazette acts we know for this company, 3 have been read. The other 12 have not been read yet: what they contain is neither established nor disproved here.
Directors · office · real estate
Not every act has been read: a resignation may be missing here
1 parcel
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25076A0142/00W000 | Wallonia | 2,485 m² | 1 · 97 m² | 10.3 m · 3 fl. |
Linked by address, not proof of ownership
Mandate history
- Board
- Permanent representative
- began earlier
| Name | Functions and periods |
|---|---|
| Bernard Delwart |
|
| Servim sa |
|
Articles of association
Full purpose
La société a pour objet la recherche et le développement, mais également la production, la transformation. le conditionnement, la vente et l'achat, l'importation et l'exportation, la représentation, le courtage, le négoce et en général, le commerce sous toutes ses formes, de produits et techniques dans le domaine de la biologie et des sciences de la vie et destinés entre autres aux domaine de l'agriculture, de la pharmacie, de la cosmétologie et de l'industrie alimentaire, cette liste étant non limitative, le tout considéré pour l'ensemble des cycles végétaux, animaux et humains. De plus, elle peut faire toutes opérations industrielles, financiéres ou commerciales, qui se rattachent directement ou indirectement à son objet, comme aussi acquérir tous immeubles, entreprendre toute industrie qui serait de nature à lui procurer des débouchés pour ses produits ou y prendre des participations de quelque manière que ce soit
Structure & network
Owners and holdings
2 owners · 3 holdingsChain of control
- Belgocodex
- Biotec
Highest known parent: Belgocodex. The sources do not say who stands above it.
Owners 2
-
100%
-
14.76%
Holdings 3
-
30.9%
- Equity €3.2mResult -€805,00224.32%
-
20.31%
According to the 2024 annual accounts of Biotec and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Acquisitions and mergers
1 transactionCapital and shareholders
- BELGOCODEX (BE 0404.755.066)
The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.
Recognitions · licences · registrations
Legal Entity Identifier
Similar companies · same sector, comparable size
Identification & contact
The company is no longer active; its Peppol card can remain until its access point withdraws it.
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.